User:Daniel Seeman/Alpha-1-antitrypsin: Difference between revisions
No edit summary |
No edit summary |
||
Line 17: | Line 17: | ||
[[Category:Alpha-1-antitrypsin]] | [[Category:Alpha-1-antitrypsin]] | ||
[[Category:Elastase inhibitor]] |
Revision as of 02:01, 2 December 2008
| |||||||||
1atu, resolution 2.70Å () | |||||||||
---|---|---|---|---|---|---|---|---|---|
| |||||||||
| |||||||||
Resources: | FirstGlance, OCA, RCSB, PDBsum | ||||||||
Coordinates: | save as pdb, mmCIF, xml |
Alpha-1-antitrypsin (or α1-antitrypsin, A1AT) is an inhibitor of Elastase and Trypsin. It is a member of the Serine Protease Inhibitor (Serpin) family, and as such undergoes a conformational change where a loop region becomes ordered as a Beta Strand[1]. In this case Trypsin is inhibited when a covalent bond is formed to A1AT. With A1AT, as with most members of the Serpin family, the transition from inactive precursor protein to active complex comes after a cleavage event. Shown is a morph, generated by the Yale Morph Server that shows A1AT going from its inactive form, to the conformation in which it is bound to Trypsin (also shown in the same animation)[2].
Role in diseaseRole in disease
Mutations of MET358 to ARG can lead to a change in specificity in the Elastase binding pocket, essentially turning the M358R mutant of A1AT into a Thrombin inhibitor by generating specificity for this new substrate. This drop in Thrombin levels can lead to hemorrhaging. [3]
ScenesScenes
See AlsoSee Also
ReferencesReferences
- ↑ Nature 455, 1189-1190 (30 October 2008)
- ↑ The Yale Morph Server
- ↑ Biochemistry, Fifth Edition, p.289.